The present invention features a formulation and method of administering the same to inhibit phosphodiesterase3 (PDE3) and increasing cAMP levels in beta cells, by providing a composition or treatment formulated with one or more processed Morinda citrifolia products, including TAHITIAN NONI.RTM. juice and juice concentrate, as derived from the Indian Mulberry plant.